Nexstim Oyj

5NX

Company Profile

  • Business description

    Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.

  • Contact

    Elimaenkatu 9 B
    Helsinki00510
    FIN

    T: +358 92727170

    https://www.nexstim.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    40

Stocks News & Analysis

stocks

Chart of the Week: BHP’s growth story faces a reality check

China’s slowing economy could weigh on BHP’s future growth.
stocks

3 best ASX growth stocks to buy for the long term

Here’s three high-quality growth companies with wide moats.
stocks

The ASX data center stock flying under the radar

While markets chase AI hype, this data centre company offers real data center earnings and a visible growth pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,036.9013.00-0.14%
CAC 408,326.3556.08-0.67%
DAX 4024,853.73145.80-0.58%
Dow JONES (US)52,658.64150.370.29%
FTSE 10010,484.9830.94-0.29%
HKSE25,008.60327.501.33%
NASDAQ26,269.23162.220.62%
Nikkei 22566,835.541,915.97-2.79%
NZX 50 Index13,614.7820.29-0.15%
S&P 5007,572.4028.810.38%
S&P/ASX 2008,840.7015.50-0.18%
SSE Composite Index3,882.4173.17-1.85%

Market Movers